KYMR vs AAPL: Which Stock is Better?
Side-by-side comparison of Kymera Therapeutics Inc and Apple Inc in 2026
KYMR
Kymera Therapeutics Inc
$86.14
AAPL
Apple Inc
$270.52
Key Metrics Comparison
| Metric | KYMR | AAPL | Winner |
|---|---|---|---|
| Market Cap | $7.27B | N/A | KYMR |
| P/E Ratio | N/A | 33.32 | AAPL |
| EPS (TTM) | $N/A | $8.11 | AAPL |
| Revenue Growth | -0.6% | 0.2% | AAPL |
| Gross Margin | -707.3% | 47.3% | AAPL |
Analyze KYMR
Full quant analysis
Analyze AAPL
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is KYMR or AAPL a better investment?
Comparing KYMR and AAPL: Kymera Therapeutics Inc has a market cap of $7.27B while Apple Inc has N/A. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between KYMR and AAPL?
KYMR (Kymera Therapeutics Inc) and AAPL (Apple Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: KYMR or AAPL?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: KYMR or AAPL?
AAPL has higher revenue growth at 0.2% vs -0.6% for KYMR.
Which company is more profitable: KYMR or AAPL?
Apple Inc (AAPL) has higher gross margins at 47.3% compared to -707.3% for KYMR.
Which is the larger company: KYMR or AAPL?
Kymera Therapeutics Inc (KYMR) is larger with a market cap of $7.27B compared to N/A for AAPL.
Should I buy KYMR or AAPL in 2026?
Both KYMR and AAPL have investment merit. KYMR trades at $86.14 while AAPL trades at $270.52. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between KYMR and AAPL stock?
Key differences: Market Cap ($7.27B vs N/A), P/E Ratio (N/A vs 33.3x), Revenue Growth (-0.6% vs 0.2%), Gross Margin (-707.3% vs 47.3%).